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Methods: The medical records of 443 patients who underwent curative 
resection for NSCLC at our institution between 1994 and 2004 were re-
viewed retrospectively. The tumor recurrence and 12 clinicopathologi-
cal factors, which may affect prognosis after recurrence, were analyzed 
using univariate and multivariate analyses. The factors assessed were: 
age, sex, tumor histology, neoadjuvant therapy, adjuvant therapy, patho-
logical stage of the initial curative resection, the patient’s acceptance of 
the treatment for the recurrent tumor, surgical method, time from initial 
surgery to recurrence, locoregional vs. distant recurrence, recurrence in 
a single organ vs. multiple, recurrence only in the lung vs. in the lung 
and/or other organ(s). 
Results: Recurrence occurred in 176 patients (39.7 %) during the 
mean follow-up period of 1.54 years. There were 129 males and 47 
females (mean age 66 yrs). The histological types were adenocarci-
noma (n=100), squamous cell carcinoma (n=60), large cell carcinoma 
(n=8), and other histological types (n=8). Ninety-four patients (53.4 %) 
had recurrence in a single organ when the recurrence was ﬁrst identi-
ﬁed; lung in 30 patients, bone in 14, brain in 11 and other organs in 39 
patients. Recurrence occurred at 1.44 years (median, range 0.1-10.0) 
after the curative operation. Median survival time was 8.4 months and 
overall 2-yr survival rate after recurrence was 34.8 %. Multivariate 
analysis showed that adenocarcinoma (p<0.0001), recurrence only in 
the lung (p=0.001), a longer time from initial surgery to recurrence 
(p=0.042) and the patient’s acceptance of the treatment for the recurrent 
tumor (p<0.0001), were signiﬁcant independent factors for improved 
prognosis. Patients with more than one of the four factors had a sig-
niﬁcantly better prognosis after recurrence. (Graph; the difference in 
survival between subgroups was statistically signiﬁcant. p= .012 for 
all factors vs. 2 or 3 factors, p< .0001 for 2 or 3 factors vs. 1 factor, p= 
.0026 for 1 factor vs. no factors).
Conclusion: Some factors for positive prognosis after NSCLC recur-
rence have been identiﬁed. Establishment of more effective treatment 
for patients with non-adenocarcinoma or extrapulmonary recurrence 
may improve prognosis of patients with recurrent NSCLC after cura-
tive resection.
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Background: A segmentectomy is a less invasive option to treat non-
small cell lung cancer (NSCLC), as is a wedge resection, in which 
local/regional relapse should be avoided. A malignant margin is an 
indicator of surgical margin relapse, even when histological ﬁndings 
are negative for a malignant margin. Thus, a cytological examination 
is considered mandatory in cases of intentional segmentectomy for 
NSCLC. We performed intentional segmentectomies for clinical stage 
IA NSCLC and conﬁrmed complete resection at the surgical margin 
using a cytological method.
Methods: Intentional segmentectomies were performed in patients 
with clinical stage IA NSCLC and we analyzed the results of those who 
met the following criteria: 1) tumor size less than 2 cm, 2) no signs of 
visceral pleura invasion, 3) no evidence of metastases in dissected hilar 
and/or mediastinal lymph nodes shown by a frozen section histological 
examination, 4) negative results in a surgical margin cytology exami-
nation using the run-across method (Figure 1) during surgery, and 5) 
completion lobectomy performed in cases with a malignant positive 
margin and/or lymph node metastasis.
Results: From 2001 to 2007, we carried out 22 intentional segmentec-
tomies in patients that met the study criteria. The median tumor size 
was 1.7 cm (range, 1.2-2.0 cm), and the tumor histology was adeno-
carcinoma in 17 cases and squamous cell carcinoma in 5. The tumor 
location was right S1 in 2, right S6 in 5, right S8 in 1, left S1+2 in 3, 
left S4 in 2, left S5 in 2, and left S6 in 7 cases. All operations were 
performed using an axillar thoracotomy, and the method of parenchyma 
division was a stapler in 17 cases and electronic knife in 5. Two cases 
had malignant positive margin cytology ﬁndings, both of which had 
a tumor location in right S6 (stapler 1, electronic knife 1), though no 
metastasized lymph nodes were found. There was a median follow-up 
period of 36 months, during which there was 1 death, due to a thoracic 
aortic aneurysm rupture. Thus, the 3-year disease speciﬁc survival rate 
was 100% and the overall 3-year survival rate was 90%, while there 
were no instances of local/regional relapse.
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Conclusion: Cytological malignant positive ﬁndings could be obtained 
during surgery using the run-across method, which is helpful for deci-
sion making regarding a completion lobectomy.
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Objective: Chronic obstructive pulmonary disease (COPD) poses a 
high risk for postoperative pulmonary complications after lung cancer 
surgery. We sought to determine the impact of this disease on long-term 
survival after surgical resection and to identify prognostic factors.
Methods: A retrospective chart review was done of 251 male patients 
with pathological stage IA lung cancer who had a lobectomy with 
systematic lymph node dissection (17.2%) out of 1461 patients who 
underwent lung cancer surgery at our hospital from January 1990 
to April 2005. The functional deﬁnition of COPD, according to the 
spirometric guidelines of the Global Initiative for Chronic Obstructive 
Lung Disease, was (forced expiratory volume in 1 second) /(forced 
vital capacity) < 70%. The postoperative complications were compared 
between the non-COPD (178 patients) and COPD (73 patients) groups. 
Overall survival and disease-free interval were analyzed using the Ka-
plan-Meier method and log rank test. Prognostic factors were identiﬁed 
by univariate and multivariate analyses.
Results: The frequencies of all pulmonary complications except 
pneumonia were similar between the two groups. Overall survival and 
disease-free interval in the COPD group were signiﬁcantly worse than 
those in the non-COPD group (p<.05). Prognostic factors were tumor 
size and severity of COPD.
Conclusion: Although the incidences of postoperative complications 
were acceptable in patients with COPD, these patients had poorer long-
term survivals due to higher incidence of tumor recurrence. We should 
be watchful not only for postoperative functional deterioration but also 
for higher recurrence of lung cancer in patients with COPD.
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Background: Video Assisted Thoracoscopic Surgery (VATS) lobec-
tomy as minimally invasive approaches has been widely applied for 
early stage non-small cell lung cancer (NSCLC) patients. Although the 
evidence in published data demonstrated the advantage of minimally 
invasive surgery, cancer-speciﬁc issues such as recurrence and survival 
rate always arose and were discussed. The aim of this study was to 
compare the outcomes between patients with conventional and VATS 
lobectomy for stage IA NSCLC using a matched-pair analysis.
Methods: We reviewed 242 patients with complete lung resections 
who underwent either conventional or video-assisted approach for 
pathological stage IA NSCLC at our institution from 1995 through 
2004. From this cohort, 48 pairs of conventional and VATS lobectomy 
patients were matched according to age (± 6 years), gender, tumor size 
(± 5mm), tumor location (side and lobe) and histology. Survival analy-
sis was performed using Kaplan-Meier estimates and the log-rank test 
was used for the equality between the groups. P values less than 0.05 
were considered statistically signiﬁcant.
Results: There were no postoperative deaths and complication rate 
were similar in the two groups. There were no signiﬁcant differences 
in recurrence rates (13%; 6 out of 48 in both groups) and all recurrence 
occurred in distant sites not in local site in both groups. Overall 5-year 
survival rate (83% in conventional approach and 77% in video-assisted 
approach) did not differ between groups (P = 0.69).
Conclusions: VATS lobectomy offered a similar prognosis provided 
by conventional lobectomy and is acceptable as the valid oncological 
surgery at least for stage IA NSCLC.
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Objective: To assess inﬂuence of mediastinal lymphadenectomy on 
postoperative level of peripheral blood lymphocytes, as well as con-
centration of interleukin 6 (IL-6) and interleukin 1 receptor antagonist 
(IL-1ra) in serum, sputum and pleural ﬂuid, in patients operated on due 
to lung cancer. 
Methods: 23 patients undergoing uncomplicated resection due to lung 
cancer (11 with right lung cancer and 12 with left lung cancer) were 
analyzed. In patients with right lung cancer systematic lymphadenec-
tomy, while in patients with left lung cancer systematic sampling was 
performed. Serum IL-6 and IL-1ra concentration was measured before 
and after surgery, and on postoperative day 1, 3, and 7, as well as in 
sputum at the end of surgery and in pleural ﬂuid on postoperative day 
1 by ELISA test. Peripheral blood lymphocyte level was assessed with 
ﬂow cytometry. 
Results: Time of surgery was higher in patients after right than after 
left thoracotomy (154.1±31.29 vs 119.6±24.81 minutes; p=0.008). The 
number of resected mediastinal lymph nodes was higher in patients 
after right than left thoracotomy (27.6±7.6 vs. 11.1±8.1; p=0.00006). 
Postoperative decrease of peripheral blood lymphocytes was signiﬁ-
cantly higher in patients after right than left thoracotomy (1.25±0.37 
vs 1.75±0.64 * 103/ìL; p=0.04). No signiﬁcant differences were found 
in serum, pleural ﬂuid and sputum concentration of IL-6 and IL-1ra 
between patients after right and left thoracotomy (Fig. 1), but negative 
